cardiovascular system
N |
• mice show no significant difference in heart weight, body weight, heart/body weight ratio, or cardiomyocyte cross-sectional area at 12 weeks; no myofibrillar disarray, necrosis, or ventricular fibrosis is observed
• other tissues with abundant Nol3 expression appear normal
• under normal living conditions, mice do not display hypertrophy or heart failure up to 9 months of age
|
• at 4 weeks after thoracic aortic banding (TAB), mutants show accelerated left ventricle dilation compared to modestly dilated left ventricles in wild-type mice
|
• marked intermuscular cardiac fibrosis is seen in banded mutant hearts compared to banded wild-type
|
• fractional shortening measured 4 weeks after TAB is significantly reduced compared to controls after TAB
|
• after conclusion of reperfusion after ischemia/reperfusion of hearts, mutant hearts have an enlarged area of infarction compared to wild-type hearts; mean size is increased 52.2% relative to wild-type
|
muscle
• fractional shortening measured 4 weeks after TAB is significantly reduced compared to controls after TAB
|
• 2 weeks after TAB, cardiomyocyte apoptosis frequency is significantly higher in mutant hearts than in banded wild-type hearts
|
respiratory system
• lung weight to body weight ratio is significantly higher after TAB relative to unbanded controls and knockouts
|
homeostasis/metabolism
• after conclusion of reperfusion after ischemia/reperfusion of hearts, mutant hearts have an enlarged area of infarction compared to wild-type hearts; mean size is increased 52.2% relative to wild-type
|
cellular
• 2 weeks after TAB, cardiomyocyte apoptosis frequency is significantly higher in mutant hearts than in banded wild-type hearts
|